CNTNAP3B inhibitors are chemical compounds designed to selectively inhibit the function of the CNTNAP3B protein, which belongs to the contactin-associated protein-like (CASPR) family. CNTNAP3B is a transmembrane protein primarily expressed in the nervous system, where it plays a significant role in mediating neuronal communication and cell-cell interactions. Like other members of the CASPR family, CNTNAP3B is thought to be involved in the organization of synaptic junctions and the maintenance of axonal integrity. It is closely associated with the proper functioning of the nodes of Ranvier, specialized regions along myelinated nerve fibers that enable the rapid conduction of electrical impulses through saltatory conduction. CNTNAP3B contributes to the structural framework that maintains these nodes and may interact with other cell adhesion molecules and extracellular matrix components critical for neural signal transmission.
Inhibitors of CNTNAP3B serve as valuable tools for investigating the molecular mechanisms governing neuronal connectivity and signal propagation. By blocking CNTNAP3B function, researchers can study the specific contributions of this protein to the organization of neural circuits and its role in the formation of functional synaptic connections. Inhibition of CNTNAP3B allows for exploration of its involvement in the stabilization of axonal junctions and how it may influence the assembly of protein complexes essential for neuronal signaling. This inhibition can also shed light on the broader implications of CNTNAP3B in neural development, synaptic plasticity, and the establishment of communication pathways between neurons. Through the use of CNTNAP3B inhibitors, scientists can further unravel the complexities of how cell adhesion proteins contribute to maintaining the integrity and functionality of the nervous system.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $66.00 $219.00 $417.00 | 97 | |
A potent inhibitor of phosphoinositide 3-kinases (PI3K), which could alter signaling pathways that indirectly affect CNTNAP3B function. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
A chemical that inhibits PI3K, potentially altering cellular processes that CNTNAP3B is involved in. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $63.00 $241.00 | 136 | |
A MAPK/ERK inhibitor that might change downstream signaling, possibly affecting proteins that interact with CNTNAP3B. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $88.00 $342.00 | 284 | |
A p38 MAP kinase inhibitor, which could modify cellular responses in pathways where CNTNAP3B participates. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
An inhibitor of c-Jun N-terminal kinase (JNK), which could influence cellular mechanisms related to CNTNAP3B’s activity. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
Inhibits mTOR signaling which could have downstream effects on proteins that interact with CNTNAP3B. | ||||||
Cyclopamine | 4449-51-8 | sc-200929 sc-200929A | 1 mg 5 mg | $92.00 $204.00 | 19 | |
A Hedgehog signaling pathway inhibitor that might indirectly influence the function of CNTNAP3B. | ||||||
DAPT | 208255-80-5 | sc-201315 sc-201315A sc-201315B sc-201315C | 5 mg 25 mg 100 mg 1 g | $99.00 $335.00 $836.00 $2099.00 | 47 | |
A gamma-secretase inhibitor that could affect the processing of proteins that modulate CNTNAP3B activity. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $39.00 $90.00 | 212 | |
An inhibitor of MEK, which might have downstream effects on CNTNAP3B through alterations in signaling pathways. | ||||||
XAV939 | 284028-89-3 | sc-296704 sc-296704A sc-296704B | 1 mg 5 mg 50 mg | $35.00 $115.00 $515.00 | 26 | |
A Tankyrase inhibitor that affects the Wnt/β-catenin pathway, potentially influencing CNTNAP3B indirectly. |